GUELPH, ON, May 28, 2024 /CNW/ - BIOREM Inc. (TSXV:BRM) ("BIOREM" or "the Company") today announced results for the three month period ended March 31, 2024. BIOREM's complete 2024 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com). Financial Summary: Three-months March 31 ended December 31 ( in CDN$'000 except per share data) 2024 2023 2023 Revenue 5,918 3,169 12,207 Gross profit 1,780 117 4,407 Ebitda* 622 (547) 3,207 Net earnings (loss) 344 (557) 2,364 Basic earnings (loss) per share